LymphedemaV1, PubMed, Checkpoint, bibRecord, 000401

Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.

Identifieur interne : 000401 ( PubMed/Checkpoint ); précédent : 000400; suivant : 000402

Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.

Auteurs : Harinder Brar [Canada] ; Liat Hogen [Canada] ; Al Covens [Canada]

Source :

Cancer [ 1097-0142 ] ; 2017.

RBID : pubmed:28117888

Descripteurs français

English descriptors

KwdEn :
- Carcinoma (economics), Carcinoma (pathology), Carcinoma (surgery), Coloring Agents, Cost-Benefit Analysis, Decision Support Techniques, Decision Trees, Female, Humans, Hysterectomy, Lymph Node Excision (economics), Lymph Node Excision (methods), Neoplasm Staging (economics), Pelvis, Quality-Adjusted Life Years, Sentinel Lymph Node Biopsy (economics), Sentinel Lymph Node Biopsy (methods), Technetium, Uterine Cervical Neoplasms (economics), Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (surgery).
MESH :
- chemical : Coloring Agents, Technetium.
- economics : Carcinoma, Lymph Node Excision, Neoplasm Staging, Sentinel Lymph Node Biopsy, Uterine Cervical Neoplasms.
- methods : Lymph Node Excision, Sentinel Lymph Node Biopsy.
- pathology : Carcinoma, Uterine Cervical Neoplasms.
- surgery : Carcinoma, Uterine Cervical Neoplasms.
- Cost-Benefit Analysis, Decision Support Techniques, Decision Trees, Female, Humans, Hysterectomy, Pelvis, Quality-Adjusted Life Years.

Abstract

The objective of this study was to determine the cost-effectiveness of radical hysterectomy (RH) and sentinel lymph node biopsy (SLNB) for the management of early-stage cervical cancer (stage IA2-IB1).

DOI: 10.1002/cncr.30509
PubMed: 28117888

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000403
to stream PubMed, to step Curation: 000403

Links to Exploration step

pubmed:28117888

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.</title>
<author><name sortKey="Brar, Harinder" sort="Brar, Harinder" uniqKey="Brar H" first="Harinder" last="Brar">Harinder Brar</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hogen, Liat" sort="Hogen, Liat" uniqKey="Hogen L" first="Liat" last="Hogen">Liat Hogen</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28117888</idno>
<idno type="pmid">28117888</idno>
<idno type="doi">10.1002/cncr.30509</idno>
<idno type="wicri:Area/PubMed/Corpus">000403</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000403</idno>
<idno type="wicri:Area/PubMed/Curation">000403</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000403</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000403</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000403</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.</title>
<author><name sortKey="Brar, Harinder" sort="Brar, Harinder" uniqKey="Brar H" first="Harinder" last="Brar">Harinder Brar</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hogen, Liat" sort="Hogen, Liat" uniqKey="Hogen L" first="Liat" last="Hogen">Liat Hogen</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Cancer</title>
<idno type="eISSN">1097-0142</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carcinoma (economics)</term>
<term>Carcinoma (pathology)</term>
<term>Carcinoma (surgery)</term>
<term>Coloring Agents</term>
<term>Cost-Benefit Analysis</term>
<term>Decision Support Techniques</term>
<term>Decision Trees</term>
<term>Female</term>
<term>Humans</term>
<term>Hysterectomy</term>
<term>Lymph Node Excision (economics)</term>
<term>Lymph Node Excision (methods)</term>
<term>Neoplasm Staging (economics)</term>
<term>Pelvis</term>
<term>Quality-Adjusted Life Years</term>
<term>Sentinel Lymph Node Biopsy (economics)</term>
<term>Sentinel Lymph Node Biopsy (methods)</term>
<term>Technetium</term>
<term>Uterine Cervical Neoplasms (economics)</term>
<term>Uterine Cervical Neoplasms (pathology)</term>
<term>Uterine Cervical Neoplasms (surgery)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Agents colorants</term>
<term>Analyse coût-bénéfice</term>
<term>Années de vie ajustées sur la qualité</term>
<term>Arbres de décision</term>
<term>Biopsie de noeud lymphatique sentinelle ()</term>
<term>Biopsie de noeud lymphatique sentinelle (économie)</term>
<term>Carcinomes ()</term>
<term>Carcinomes (anatomopathologie)</term>
<term>Carcinomes (économie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie</term>
<term>Lymphadénectomie ()</term>
<term>Lymphadénectomie (économie)</term>
<term>Pelvis</term>
<term>Stade de la tumeur (économie)</term>
<term>Techniques d'aide à la décision</term>
<term>Technétium</term>
<term>Tumeurs du col de l'utérus ()</term>
<term>Tumeurs du col de l'utérus (anatomopathologie)</term>
<term>Tumeurs du col de l'utérus (économie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Coloring Agents</term>
<term>Technetium</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinomes</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Carcinoma</term>
<term>Lymph Node Excision</term>
<term>Neoplasm Staging</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term>
<term>Carcinomes</term>
<term>Lymphadénectomie</term>
<term>Stade de la tumeur</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cost-Benefit Analysis</term>
<term>Decision Support Techniques</term>
<term>Decision Trees</term>
<term>Female</term>
<term>Humans</term>
<term>Hysterectomy</term>
<term>Pelvis</term>
<term>Quality-Adjusted Life Years</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Agents colorants</term>
<term>Analyse coût-bénéfice</term>
<term>Années de vie ajustées sur la qualité</term>
<term>Arbres de décision</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Carcinomes</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie</term>
<term>Lymphadénectomie</term>
<term>Pelvis</term>
<term>Techniques d'aide à la décision</term>
<term>Technétium</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The objective of this study was to determine the cost-effectiveness of radical hysterectomy (RH) and sentinel lymph node biopsy (SLNB) for the management of early-stage cervical cancer (stage IA2-IB1).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28117888</PMID>
<DateCreated><Year>2017</Year>
<Month>01</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>08</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>08</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0142</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>123</Volume>
<Issue>10</Issue>
<PubDate><Year>2017</Year>
<Month>May</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Cancer</Title>
<ISOAbbreviation>Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.</ArticleTitle>
<Pagination><MedlinePgn>1751-1759</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.30509</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The objective of this study was to determine the cost-effectiveness of radical hysterectomy (RH) and sentinel lymph node biopsy (SLNB) for the management of early-stage cervical cancer (stage IA2-IB1).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A simple decision tree model was developed to follow a simulated cohort of patients with early-stage cervical cancer treated with RH and 1 of 3 lymph node assessment strategies: systematic pelvic lymph node dissection (PLND), SLNB using technetium 99 (Tc99) and blue dye, and SLNB using Tc99 only. SLNB using indocyanine green (ICG) was used as an exploratory strategy. Relevant studies were identified to extract the probability data and utility parameters and to estimate quality-adjusted life-years (QALYs) and absolute life-years (ALYs). Only direct medical costs were modeled, and the time horizon for the study was 5 years.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">SLNB using Tc99 and blue dye cost $21,089 and yielded 4.54 QALYs and 4.90 ALYs. PLND cost $22,353 and yielded 4.47 QALYs and 4.91 ALYs. SLNB using blue dye and Tc99 was the most cost-effective strategy when ALYs were considered with an incremental cost-effectiveness ratio (ICER) of $144,531. When QALYs were considered, the SLNB technique using Tc99 and blue dye dominated all other strategies. SLNB using ICG cost $20,624 and yielded 4.90 ALYs and 4.54 QALYs. It was clinically superior to and less expensive than all other strategies when QALYs were the outcome of interest and had an ICER of $221,171 per ALY in comparison with RH plus PLND.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SLNB using Tc99 and blue dye with ultrastaging is considered the most cost-effective strategy with respect to 5-year progression-free survival and morbidity-free survival. Although it was included only as an exploratory strategy in this study, SLNB with ICG has the potential to be the most cost-effective strategy. Cancer 2017;123:1751-1759. © 2017 American Cancer Society.</AbstractText>
<CopyrightInformation>© 2017 American Cancer Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brar</LastName>
<ForeName>Harinder</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Division of Gynecological Oncology, Odette Cancer Center, Sunnybrook Hospital, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hogen</LastName>
<ForeName>Liat</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Division of Gynecological Oncology, Odette Cancer Center, Sunnybrook Hospital, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Covens</LastName>
<ForeName>Al</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Division of Gynecological Oncology, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Division of Gynecological Oncology, Odette Cancer Center, Sunnybrook Hospital, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>01</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Cancer</MedlineTA>
<NlmUniqueID>0374236</NlmUniqueID>
<ISSNLinking>0008-543X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7440-26-8</RegistryNumber>
<NameOfSubstance UI="D013667">Technetium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003661" MajorTopicYN="N">Decision Support Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007044" MajorTopicYN="Y">Hysterectomy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019057" MajorTopicYN="Y">Quality-Adjusted Life Years</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013667" MajorTopicYN="N">Technetium</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cervical cancer</Keyword>
<Keyword MajorTopicYN="N">cost-effectiveness</Keyword>
<Keyword MajorTopicYN="N">indocyanine green</Keyword>
<Keyword MajorTopicYN="N">lymphadenectomy</Keyword>
<Keyword MajorTopicYN="N">lymphedema</Keyword>
<Keyword MajorTopicYN="N">sentinel node biopsy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>10</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2016</Year>
<Month>11</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>11</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>1</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>8</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>1</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28117888</ArticleId>
<ArticleId IdType="doi">10.1002/cncr.30509</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Ontario"><name sortKey="Brar, Harinder" sort="Brar, Harinder" uniqKey="Brar H" first="Harinder" last="Brar">Harinder Brar</name>
</region>
<name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name>
<name sortKey="Hogen, Liat" sort="Hogen, Liat" uniqKey="Hogen L" first="Liat" last="Hogen">Liat Hogen</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000401 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000401 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:28117888
   |texte=   Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:28117888" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.

Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki